Dr Federico Goodsaid, CEO of Puerto Rico’s first biopharmaceutical start-up MBQ Pharma, has previously worked at Vertex Pharmaceuticals and TOMA Biosciences and is considered an expert in regulatory affairs. Here, he highlights the encouraging results MBQ Pharma has achieved in preclinical efficacy and safety trials and acknowledges the backing the start-up has received from the Puerto Rican life sciences community.
For the first time in the history of the island, we have the opportunity to take intellectual property from a university and use it for potential commercialization
